Fengxiao Zhang

2.2k total citations
48 papers, 1.2k citations indexed

About

Fengxiao Zhang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Fengxiao Zhang has authored 48 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 11 papers in Oncology. Recurrent topics in Fengxiao Zhang's work include PARP inhibition in cancer therapy (8 papers), Cardiac Fibrosis and Remodeling (5 papers) and Lipoproteins and Cardiovascular Health (3 papers). Fengxiao Zhang is often cited by papers focused on PARP inhibition in cancer therapy (8 papers), Cardiac Fibrosis and Remodeling (5 papers) and Lipoproteins and Cardiovascular Health (3 papers). Fengxiao Zhang collaborates with scholars based in China, United States and Italy. Fengxiao Zhang's co-authors include Kai Huang, Dan Huang, Meng Du, Kun Huang, Cheng Wang, Xiangrao Li, Wenjing Xu, Xi Luo, Minglu Liang and Xin Tan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Fengxiao Zhang

46 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengxiao Zhang China 21 521 272 252 250 207 48 1.2k
Wen Gu China 21 368 0.7× 148 0.5× 162 0.6× 269 1.1× 153 0.7× 74 1.1k
Xiaoming Xing China 22 438 0.8× 266 1.0× 151 0.6× 483 1.9× 129 0.6× 90 1.3k
Weihua Qiu China 24 738 1.4× 307 1.1× 206 0.8× 585 2.3× 169 0.8× 73 1.7k
Hiroyoshi Watanabe Japan 22 440 0.8× 144 0.5× 82 0.3× 257 1.0× 142 0.7× 104 1.5k
Hengyuan Li China 21 342 0.7× 180 0.7× 75 0.3× 272 1.1× 169 0.8× 69 1.4k
Jisheng Yang United States 14 513 1.0× 148 0.5× 121 0.5× 186 0.7× 136 0.7× 26 1.4k
Johanna Ungerstedt Sweden 20 855 1.6× 82 0.3× 89 0.4× 206 0.8× 255 1.2× 40 1.4k
Aiko Yamaguchi Japan 21 547 1.0× 143 0.5× 115 0.5× 349 1.4× 120 0.6× 62 1.4k
Su-Ning Zhu Canada 15 601 1.2× 216 0.8× 339 1.3× 177 0.7× 993 4.8× 18 2.0k
Sean Y. Kassim United States 8 300 0.6× 232 0.9× 78 0.3× 132 0.5× 406 2.0× 9 1.0k

Countries citing papers authored by Fengxiao Zhang

Since Specialization
Citations

This map shows the geographic impact of Fengxiao Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengxiao Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengxiao Zhang more than expected).

Fields of papers citing papers by Fengxiao Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengxiao Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengxiao Zhang. The network helps show where Fengxiao Zhang may publish in the future.

Co-authorship network of co-authors of Fengxiao Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Fengxiao Zhang. A scholar is included among the top collaborators of Fengxiao Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengxiao Zhang. Fengxiao Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Kaiqiang, Fengxiao Zhang, Zehui Yu, et al.. (2025). The dispersion state and NO x -SCR properties of VO x species on V 2 O 5 catalysts with different preferentially exposed facets of TiO 2 supports. Catalysis Science & Technology. 15(20). 6222–6230.
2.
Jiang, Siyu, Dong Yin, Long Chen, et al.. (2025). Erucin Alleviates Cardiac Hypertrophy by Improving Mitochondrial Function via Nrf2‐Sirt3 Pathway. Phytotherapy Research. 39(6). 2989–3001.
3.
Xu, Wenjing, Yichen Wu, Hao Jiang, et al.. (2025). Poly(ADP-ribose) polymerase 1 orchestrates vascular smooth muscle cell homeostasis in arterial disease. Experimental & Molecular Medicine. 57(8). 1686–1699. 1 indexed citations
4.
Zhang, Fengxiao, et al.. (2024). Electrical Tree Properties and Mechanism of Modified Aramid/Epoxy Composites. IEEE Transactions on Dielectrics and Electrical Insulation. 32(2). 903–912. 1 indexed citations
5.
Zhong, Yi, Dandan Huang, Yang Liu, et al.. (2023). LncRNA Nron deficiency protects mice from diet-induced adiposity and hepatic steatosis. Metabolism. 148. 155609–155609. 6 indexed citations
6.
Du, Meng, Cheng Wang, Bing Liu, et al.. (2022). The role of long noncoding RNA Nron in atherosclerosis development and plaque stability. iScience. 25(3). 103978–103978. 11 indexed citations
7.
Du, Meng, Xiaojing Wang, Yuan Lin, et al.. (2020). Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice. Journal of Hepatology. 73(6). 1333–1346. 29 indexed citations
8.
Peng, Jiangtong, Minglu Liang, Feng Zhu, et al.. (2020). 25-Hydroxycholesterol protects against myocardial ischemia-reperfusion injury via inhibiting PARP activity. International Journal of Biological Sciences. 16(2). 298–308. 24 indexed citations
9.
Wang, Cheng, et al.. (2019). Visfatin Level and The Risk of Hypertension and Cerebrovascular Accident: A Systematic Review and Meta-Analysis. Hormone and Metabolic Research. 51(4). 220–229. 19 indexed citations
10.
Du, Meng, Xiaojing Wang, Xiaoxiang Mao, et al.. (2019). Absence of Interferon Regulatory Factor 1 Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice. Theranostics. 9(16). 4688–4703. 33 indexed citations
11.
12.
Wang, Cheng, Wenjing Xu, Jie An, et al.. (2019). Poly(ADP-ribose) polymerase 1 accelerates vascular calcification by upregulating Runx2. Nature Communications. 10(1). 1203–1203. 107 indexed citations
13.
Du, Meng, Yuan Lin, Xin Tan, et al.. (2017). The LPS-inducible lncRNA Mirt2 is a negative regulator of inflammation. Nature Communications. 8(1). 2049–2049. 213 indexed citations
14.
Lin, Wei, Panpan Zhang, Hua Chen, et al.. (2017). Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease. Arthritis Research & Therapy. 19(1). 25–25. 92 indexed citations
15.
Huang, Kun, Meng Du, Xin Tan, et al.. (2016). PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease. Journal of Hepatology. 66(5). 962–977. 79 indexed citations
16.
Zhang, Yanqing, Cheng Wang, Fengxiao Zhang, et al.. (2016). Inhibition of Poly(ADP-Ribose) Polymerase-1 Protects Chronic Alcoholic Liver Injury. American Journal Of Pathology. 186(12). 3117–3130. 21 indexed citations
17.
Wang, Lei, et al.. (2014). Application of high frequency color Doppler ultrasound in the monitoring of rheumatoid arthritis treatment. Experimental and Therapeutic Medicine. 8(6). 1807–1812. 9 indexed citations
18.
Liu, Yang, Kun Huang, Xiangrao Li, et al.. (2013). Identification of Poly(ADP-Ribose) Polymerase-1 as a Cell Cycle Regulator through Modulating Sp1 Mediated Transcription in Human Hepatoma Cells. PLoS ONE. 8(12). e82872–e82872. 26 indexed citations
19.
Zhang, Fengxiao, Yan Wang, Lin Wang, et al.. (2013). Poly(ADP-ribose) Polymerase 1 Is a Key Regulator of Estrogen Receptor α-dependent Gene Transcription. Journal of Biological Chemistry. 288(16). 11348–11357. 57 indexed citations
20.
Wang, Yan, Lin Wang, Fengxiao Zhang, et al.. (2012). Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in rats. International Journal of Cardiology. 167(5). 2285–2293. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen Gu Breakdown of academic impact, for papers by Xiaoming Xing Breakdown of academic impact, for papers by Weihua Qiu Breakdown of academic impact, for papers by Hiroyoshi Watanabe Breakdown of academic impact, for papers by Hengyuan Li Breakdown of academic impact, for papers by Jisheng Yang Breakdown of academic impact, for papers by Johanna Ungerstedt Breakdown of academic impact, for papers by Aiko Yamaguchi Breakdown of academic impact, for papers by Su-Ning Zhu Breakdown of academic impact, for papers by Sean Y. Kassim
Rankless by CCL
2026